StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

2,2'-((2-Hydroxyethyl)imino)bis(N-(1,1-dimethyl-2-phenylethyl)-N-methyl-acetamid

Oxethazaine

HCID 4621
Neue Reaktion
Drucken

Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen

GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
126-27-2
Standard-SMILES
CN(C(=O)CN(CCO)CC(=O)N(C)C(C)(C)Cc1ccccc1)C(C)(C)Cc1ccccc1
InChIKey
FTLDJPRFCGDUFH-UHFFFAOYSA-N
Summenformel
C28H41N3O3
Durchschnittliche Molmasse
467,6 g/mol
Monoisotopische Masse
467,31479218

Überblick

Oxethazaine is a white powder. (NTP, 1992)

Namen und Bezeichner

Bevorzugter Name
Oxethazaine
IUPAC
2-[2-hydroxyethyl-[2-[methyl-(2-methyl-1-phenylpropan-2-yl)amino]-2-oxoethyl]amino]-N-methyl-N-(2-methyl-1-phenylpropan-2-yl)acetamide
Lokaler Name
2,2'-((2-Hydroxyethyl)imino)bis(N-(1,1-dimethyl-2-phenylethyl)-N-methyl-acetamid
Englischer Name
Oxethazaine
Summenformel
C28H41N3O3
Molmasse
467.64

Namen und Synonyme

Oxethazaine126-27-2OxetacaineOxethacaineOxaineMuthesaStrocainOxetacainaoxethazineOxetacainumWy-806WY 806
Weitere Namen anzeigen
fh099C12552mutesatepiltamucainemucoxin
DTXSID0025818Acetamide, 2,2'-((2-hydroxyethyl)imino)bis(N-(1,1-dimethyl-2-phenylethyl)-N-methyl-FH 099NSC-758444IP8QT76V17Acetamide, 2,2'-[(2-hydroxyethyl)imino]bis[N-(1,1-dimethyl-2-phenylethyl)-N-methyl-DTXCID6058182-Di(N-methyl-N-phenyl-tert-butyl-carbamoylmethyl)aminoethanol

Datenbank-Bezeichner

CAS
126-27-2
PubChem CID
4621
DTXSID
DTXSID0025818
ChEMBL
CHEMBL127592
ChEBI
CHEBI:31947
UNII
IP8QT76V17
EC Number
204-780-5
Nikkaji
J2.510K

Eigenschaften

Berechnete StruktureigenschaftenWird ergänzt

XLogP
3,8
Polarare Oberfläche (TPSA)
64,1 Ų
H-Brücken-Donoren
1
H-Brücken-Akzeptoren
4
Frei drehbare Bindungen
12
Schwere Atome
34
Formalladung
0
Komplexität
585

Experimentelle und physikochemische Eigenschaften

Drugs · 2 Einträge

Pharmaceuticals -> Listed in ZINC15

Pharmaceuticals

Solubility · 2 Einträge

less than 1 mg/mL at 73 °F (NTP, 1992)

<0.1 g/100 ml at 23 ºC

Human DrugsPharmaceuticals
Melting Point · 2 Einträge

219 to 220 °F (NTP, 1992)

100-101 ºC

Physical DescriptionOxethazaine is a white powder. (NTP, 1992)
Dissociation Constants6.25
Collision Cross Section · 2 Einträge

215.22 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

213.7 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physikochemische Eigenschaften

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 4 Einträge

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 40 reports by companies from 1 notifications to the ECHA C&L Inventory.

Gefahrenhinweise

Other Safety InformationIMAP assessments - Acetamide, 2,2'-[(2-hydroxyethyl)imino]bis[N-(1,1-dimethyl-2-phenylethyl)-N-methyl]-: Environment tier I assessment
Fire HazardsFlash point data are not available for this chemical, but it is probably combustible. (NTP, 1992)
Reactive GroupAlcohols and Polyols
Reactivity Profile · 1 Eintrag

A hydroxylated amide. Organic amides/imides react with azo and diazo compounds to generate toxic gases. Flammable gases are formed by the reaction of organic amides/imides with strong reducing agents. Amides are very weak bases (weaker than water). Imides are less basic yet and in fact react with strong bases to form salts. That is, they can react as acids. Mixing amides with dehydrating agents such as P2O5 or SOCl2 generates the corresponding nitrile. The combustion of these compounds generates mixed oxides of nitrogen (NOx).

Air and Water ReactionsInsoluble in water.
Hazard Classes and CategoriesAcute Tox. 4 (100%)

Sicherheit und Schutzausrüstung

Chemie und Industrie

Pharmakologische Informationen

ATC Code · 2 Einträge

C - Cardiovascular system

QC - Cardiovascular system

Protein BindingDue to the low half-life, it is thought that oxetacaine, when absorbed, presents a very low protein plasma binding.
Pharmacodynamics · 1 Eintrag

Oxetacaine improves common gastrointestinal symptoms. Oxetacaine is part of the anesthetic antacids which increase the gastric pH while providing relief from pain for a longer period of duration at a lower dosage. This property has been reported to relieve the symptoms of hyperacidity. Oxetacaine is reported to produce a reversible loss of sensation and to provide a prompt and prolonged relief of pain. In vitro, oxetacaine was showed to produce an antispasmodic action on the smooth muscle and block the action of serotonin. The local efficacy of oxetacaine has been proven to be 2000 times more potent than lignocaine and 500 times more potent than cocaine. Its anesthetic action produces the loss of sensation which can be explained by its inhibitory activity against the nerve impulses and de decrease in permeability of the cell membrane.

Mechanism of Action · 1 Eintrag

Oxetacaine inhibits gastric acid secretion by suppressing gastrin secretion. Moreover, oxetacaine exerts a local anesthetic effect on the gastric mucosa. This potent local anesthetic effect of oxetacaine may be explained by its unique chemical characteristics in which, as a weak base, it is relatively non-ionized in acidic solutions whereas its hydrochloride salt is soluble in organic solvents and it can penetrate cell membranes. Oxetacaine diminishes the conduction of sensory nerve impulses near the application site which in order reduces the permeability of the cell membrane to sodium ions. This activity is performed by the incorporation of the unionized form into the cell membrane.

Biological Half-LifeOxetacaine presents a very short half-life of approximately one hour.
Metabolism/Metabolites · 1 Eintrag

Oxetacaine is rapidly and extensively metabolized hepatically. After metabolism, there is a formation of primary metabolites such as beta-hydroxy-mephentermine and beta-hydroxy-phentermine. The major metabolites are found in the plasma in insignificant amounts.

Zugehörige Reaktionen

0
Reaktionsaufzeichnung erstellen
Noch keine zugehörigen Reaktionen

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
Schmelzpunkt
104 · 104-105°C
Siedepunkt
570.1 °C · 570.1°C (rough estimate)
Dichte
1.0974 · 1.0974 (rough estimate)
Brechungsindex
1.78 · 1.7800 (estimate)
storage temp.
Refrigerator
Löslichkeit
Practically insoluble in water; freely soluble in methanol; soluble in ethyl acetate.
pka
14.62 · 14.62±0.10(Predicted)
Aggregatzustand
Solid
Farbe
White to Off-White
Wasserlöslichkeit
0.1 g/100 · <0.1 g/100 mL at 23 ºC
Major Application
forensics and toxicologypharmaceutical (small molecule)veterinary
InChI
1S/C28H41N3O3/c1-27(2,19-23-13-9-7-10-14-23)29(5)25(33)21-31(17-18-32)22-26(34)30(6)28(3,4)20-24-15-11-8-12-16-24/h7-16,32H,17-22H2,1-6H3
InChIKey
FTLDJPRFCGDUFH-UHFFFAOYSA-N
SMILES
CN(C(=O)CN(CCO)CC(=O)N(C)C(C)(C)Cc1ccccc1)C(C)(C)Cc2ccccc2
CAS Datenbank
126 · 126-27-2(CAS DataBase Reference)
EPA chemische Informationen
Oxethazaine (126-27-2)
Fire FightingFires involving this compound should be controlled with a dry chemical, carbon dioxide or Halon extinguisher. (NTP, 1992)
First Aid · 1 Eintrag

EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.

Nonfire Spill Response · 1 Eintrag

SMALL SPILLS AND LEAKAGE: You should dampen the solid spill material with acetone, then transfer the dampened material to a suitable container. Use absorbent paper dampened with acetone to pick up any remaining material. Seal your contaminated clothing and the adsorbent paper in a vapor-tight plastic bag for eventual disposal. Solvent wash all contaminated surfaces with acetone followed by washing with a strong soap and water solution. Do not reenter the contaminate area until the Safety Officer (or other responsible person) has verified that the area has been properly cleaned.

Personal Protective Equipment (PPE) · 1 Eintrag

RECOMMENDED RESPIRATOR: Where the neat test chemical is weighed and diluted, wear a NIOSH-approved half face respirator equipped with an organic vapor/acid gas cartridge (specific for organic vapors, HCl, acid gas and SO2) with a dust/mist filter. (NTP, 1992)

Sicherheitsdaten

wgk
3
RTECS-Nr.
AC3325000
risk_code
22
Toxizität
LD50 oral in rat: 1gm/kg
hazard_code
Xn
safety_code
36
Speicherklasse
11 - Combustible Solids
Hazard Classifications
Acute Tox. 4 Oral
MeSH Pharmacological Classification · 1 Eintrag

Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate.

Absorption, Distribution and Excretion · 4 Einträge

A peak plasma concentration of oxetacaine of approximately 20 ng/ml is attained about one hour after oral administration. LEss than 1/3 of the administered dose is absorbed as it undergoes extensive metabolism.

Less than 0.1% of the amdinistered dose is recovered in urine within 24 hours in the form of unchanged oxetacaine or its metabolites.

This pharmacokinetic property has not been studied.

This pharmacokinetic property has not been studied.

Verwendung und Herstellung

UsesUse (kg; approx.) in Germany (2009): >50
Use ClassificationPharmaceuticals

Anwendungen

VerwendenA potent local anesthetic that is active even in acidic conditions. It is used (usually in combination with an antacid) for the relief of pain associated with peptic ulcer disease or esophagitis.

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

2-Aminoethanol